HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ergosterol-loaded poly(lactide-co-glycolide) nanoparticles with enhanced in vitro antitumor activity and oral bioavailability.

AbstractAIM:
Ergosterol is a plant sterol with anti-tumor and anti-angiogenic activities, but is poorly soluble. In this study, we attempted to enhance its anti-tumor action and oral bioavailability via poly(lactide-co-glycolide) (PLGA) nanoparticle encapsulation.
METHODS:
Ergosterol-loaded PLGA nanoparticles (NPs/Erg) were prepared using the emulsion/solvent evaporation technique. Their physicochemical properties were characterized, and their cytotoxicity against human cancer cell lines was evaluated with MTT assay. The pharmacokinetics and tissue distribution of NPs/Erg were investigated in rats and mice, respectively.
RESULTS:
NPs/Erg were spherical in shape with a particle size of 156.9±4.8 nm and a Zeta potential of -19.27±1.13 mV, and had acceptable encapsulation efficiency and loading capacity. NPs/Erg exerted much stronger cytotoxicity against human cancer cells than the free ergosterol, and showed significantly reduced IC50 values (14.69±0.48 μg/mL in glioma U251 cells; 9.43±0.52 μg/mL in breast cancer MCF-7 cells; 4.70±0.41 μg/mL in hepatoma HepG2 cells). After oral administration of a single dose in rats, NPs/Erg displayed a prolonged plasma circulation with a 4.9-fold increase of oral bioavailability compared with the free ergosterol. After mice received NPs/Erg, the ergosterol in NPs/Erg was rapidly distributed in stomach, kidneys, liver, brain, spleen, and virtually non-existent in heart and lungs. The presence of NPs/Erg in brain was particularly improved compared with the free ergosterol.
CONCLUSION:
The PLGA nanoparticles serve as a promising carrier for the poorly soluble ergosterol and significantly improve its bioavailability, biodistribution and in vitro anti-tumor activities.
AuthorsHui-Yun Zhang, Caleb Kesse Firempong, Yuan-Wen Wang, Wen-Qian Xu, Miao-Miao Wang, Xia Cao, Yuan Zhu, Shan-Shan Tong, Jiang-Nan Yu, Xi-Ming Xu
JournalActa pharmacologica Sinica (Acta Pharmacol Sin) Vol. 37 Issue 6 Pg. 834-44 (Jun 2016) ISSN: 1745-7254 [Electronic] United States
PMID27133301 (Publication Type: Journal Article)
Chemical References
  • Antineoplastic Agents
  • Drug Carriers
  • Polyglactin 910
  • Ergosterol
Topics
  • Administration, Oral
  • Animals
  • Antineoplastic Agents (administration & dosage, pharmacokinetics, pharmacology)
  • Biological Availability
  • Cell Line, Tumor
  • Cell Survival (drug effects)
  • Drug Carriers (chemistry)
  • Ergosterol (administration & dosage, pharmacokinetics, pharmacology)
  • Humans
  • Male
  • Mice
  • Nanoparticles (chemistry)
  • Neoplasms (drug therapy, metabolism, pathology)
  • Polyglactin 910 (chemistry)
  • Rats, Sprague-Dawley

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: